FDA Inspection
MEDGEL PRIVATE LIMITEDMEDGEL PRIVATE LIMITED – FDA Inspection, Jan 25, 2019
Record Details
This FDA Inspection record concerns MEDGEL PRIVATE LIMITED, with an inspection on January 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2eb09e36-1dfe-4238-9846-116ebfa23147
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1077046
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.142Written warehousing procedures established/followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of MEDGEL PRIVATE LIMITED
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 21, 2025 | VAI | Office of Inspections and Investigations | Drug Quality Assurance |
| January 27, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 6, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for MEDGEL PRIVATE LIMITED
- FDA Inspection 1261975 - 2025-02-21
- FDA Inspection 1196836 - 2023-01-27
- FDA Inspection 986369 - 2016-05-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.